Pratik Abhishek*, Ashok Tarachand Kamble, Pankaj Gharde, Akshay Bora, Suvit Jumde and Priya Singh Kushwah


Introduction: Acute pancreatitis is an inflammation and autodigestion of parenchyma of pancreas which lead to injury or destruction of acinar components. It can be initiated by factors, like gallstones, alcohol, trauma, and infections, etc.The mortality and morbidity of mild acute pancreatitis is low but patients with severe acute pancreatitis commonly develop complications and have a mortality of 10-50 %, inspite of all available treatment strategies. Octreotide is a synthetic, a long acting octapeptide analogue of the native hormone somatostatin, became available in 1982. It is a powerful inhibitor of basal and stimulated exocrine pancreatic secretion in healthy volunteers, and can be given subcutaneously. Octreotide have been shown to inhibit both pancreatic endocrine and exocrine function.This study has been conducted to study the etiology of acute pancreatitis and to see the role of octreotide in management of acute pancreatitis. Materials and methods: This is a prospective study consisting of two groups of 25 patients each. One group was treated with octreotide whereas the other group was treated without injection octreotide. Both the groups received antibiotics,analgesics,fluid support in addition.Response was assessed on the sequential assessment of serum amylase, serum lipase and abdominal ultrasound. Results: Results were analysed in view of age distribution, gender distribution, clinical features, etiology, biochemical response and radiological response.Statistical software was used to see the statistical significance in comparision. Discussion: Results of the present study was compared with the existing literature on acute pancreatitis, etiological factors and role of octreotide. Conclusion: This study was undertaken to see the etiology of acute pancreatitis in our rural set up and the effect of subcutaneous octreotide on the serum levels of amylase and lipase in patients with acute pancreatitis. The idea was to see if octreotide can significantly reduce the high levels of serum amylase and lipase in patients with acute pancreatitis. Subcutaneous octreotide reduced the levels of both the enzymes in all cases. So it can be stated that subcutaneous injection of octreotide can be used in the management strategy of acute pancreatitis.It helps in preventing the enzyme related damage to the pancreas.

Keywords: acute pancreatitis, serum amylase, serum lipase, octreotide.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    SEPTEMBER 2018 Issue has been successfully launched on 1 September 2018

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction